Eiken Chemical Co., Ltd. (TYO:4549)
2,173.00
-5.00 (-0.23%)
Feb 27, 2025, 3:30 PM JST
Eiken Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Revenue | 40,199 | 40,052 | 43,271 | 42,996 | 38,667 | 36,585 | Upgrade
|
Revenue Growth (YoY) | 0.74% | -7.44% | 0.64% | 11.20% | 5.69% | 2.30% | Upgrade
|
Cost of Revenue | 23,769 | 23,328 | 22,765 | 22,423 | 20,140 | 20,353 | Upgrade
|
Gross Profit | 16,430 | 16,724 | 20,506 | 20,573 | 18,527 | 16,232 | Upgrade
|
Selling, General & Admin | 9,895 | 9,407 | 8,963 | 8,776 | 8,829 | 8,259 | Upgrade
|
Research & Development | 3,939 | 3,939 | 4,065 | 3,408 | 3,086 | 3,332 | Upgrade
|
Operating Expenses | 13,833 | 13,345 | 13,049 | 12,184 | 11,914 | 11,608 | Upgrade
|
Operating Income | 2,597 | 3,379 | 7,457 | 8,389 | 6,613 | 4,624 | Upgrade
|
Interest Expense | -17 | -17 | -16 | -29 | -2 | -4 | Upgrade
|
Interest & Investment Income | 15 | 12 | 18 | 20 | 19 | 12 | Upgrade
|
Currency Exchange Gain (Loss) | 82 | 50 | 14 | 32 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | 165 | 144 | 108 | 95 | 178 | 90 | Upgrade
|
EBT Excluding Unusual Items | 2,842 | 3,568 | 7,581 | 8,507 | 6,808 | 4,722 | Upgrade
|
Gain (Loss) on Sale of Investments | 49 | - | 43 | - | -1 | 33 | Upgrade
|
Gain (Loss) on Sale of Assets | -6 | -65 | -33 | -26 | -48 | -32 | Upgrade
|
Other Unusual Items | 64 | - | 1 | - | 110 | - | Upgrade
|
Pretax Income | 2,949 | 3,503 | 7,592 | 8,481 | 6,869 | 4,723 | Upgrade
|
Income Tax Expense | 770 | 869 | 1,856 | 2,263 | 1,825 | 1,185 | Upgrade
|
Net Income | 2,179 | 2,634 | 5,736 | 6,218 | 5,044 | 3,538 | Upgrade
|
Net Income to Common | 2,179 | 2,634 | 5,736 | 6,218 | 5,044 | 3,538 | Upgrade
|
Net Income Growth | -26.04% | -54.08% | -7.75% | 23.28% | 42.57% | 2.64% | Upgrade
|
Shares Outstanding (Basic) | 34 | 37 | 37 | 37 | 37 | 37 | Upgrade
|
Shares Outstanding (Diluted) | 34 | 37 | 37 | 37 | 37 | 37 | Upgrade
|
Shares Change (YoY) | -8.51% | -0.62% | 0.12% | 0.10% | 0.09% | 0.09% | Upgrade
|
EPS (Basic) | 62.50 | 71.69 | 155.17 | 168.26 | 136.63 | 95.93 | Upgrade
|
EPS (Diluted) | 61.98 | 71.10 | 153.86 | 167.01 | 135.60 | 95.21 | Upgrade
|
EPS Growth | -21.39% | -53.79% | -7.87% | 23.16% | 42.42% | 2.55% | Upgrade
|
Free Cash Flow | - | 1,830 | 4,369 | 3,341 | 3,897 | 3,153 | Upgrade
|
Free Cash Flow Per Share | - | 49.39 | 117.19 | 89.72 | 104.76 | 84.83 | Upgrade
|
Dividend Per Share | 52.000 | 51.000 | 51.000 | 51.000 | 41.000 | 30.000 | Upgrade
|
Dividend Growth | 0% | 0% | 0% | 24.39% | 36.67% | 0% | Upgrade
|
Gross Margin | - | 41.76% | 47.39% | 47.85% | 47.91% | 44.37% | Upgrade
|
Operating Margin | 6.46% | 8.44% | 17.23% | 19.51% | 17.10% | 12.64% | Upgrade
|
Profit Margin | 5.42% | 6.58% | 13.26% | 14.46% | 13.04% | 9.67% | Upgrade
|
Free Cash Flow Margin | - | 4.57% | 10.10% | 7.77% | 10.08% | 8.62% | Upgrade
|
EBITDA | 5,074 | 5,705 | 9,582 | 10,447 | 8,324 | 6,251 | Upgrade
|
EBITDA Margin | - | 14.24% | 22.14% | 24.30% | 21.53% | 17.09% | Upgrade
|
D&A For EBITDA | 2,477 | 2,326 | 2,125 | 2,058 | 1,711 | 1,627 | Upgrade
|
EBIT | 2,597 | 3,379 | 7,457 | 8,389 | 6,613 | 4,624 | Upgrade
|
EBIT Margin | - | 8.44% | 17.23% | 19.51% | 17.10% | 12.64% | Upgrade
|
Effective Tax Rate | - | 24.81% | 24.45% | 26.68% | 26.57% | 25.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.